![Standish M. Fleming](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Standish M. Fleming
Oprichter bij
Forward Ventures Services LLC
Profiel
Standish M.
Fleming is the founder and the Founding Managing Partner of Forward Ventures Services LLC, which was founded in 1993.
He is currently the Director at CONNECT since 2011.
Mr. Fleming has also held former positions as a Director at Kémia, Inc., Acorda Therapeutics, Inc., Nereus Pharmaceuticals, Inc., Gryphon Therapeutics, Inc., AriZeke Pharmaceuticals, Inc., and Viracta Subsidiary, Inc. Additionally, he served as an Independent Director at Ambit Biosciences Corp.
from 2001 to 2014.
Mr. Fleming obtained his undergraduate degree from Amherst College in 1969 and an MBA from UCLA Anderson School of Management in 1986.
Actieve functies van Standish M. Fleming
| Bedrijven | Functie | Begin |
|---|---|---|
Forward Ventures Services LLC
 Forward Ventures Services LLC Investment ManagersFinance Forward Ventures invests in companies located in the United States. The firm targets operating in the fields on life sciences and bio pharmaceuticals sectors. It provides financing for early stage capital requirements. | Oprichter | 17-11-2010 |
CONNECT
 CONNECT Miscellaneous Commercial ServicesCommercial Services Offers education, networking and recognitions services | Directeur/Bestuurslid | 02-11-2010 |
Eerdere bekende functies van Standish M. Fleming
| Bedrijven | Functie | Einde |
|---|---|---|
| AMBIT BIOSCIENCES CORP | Directeur/Bestuurslid | 10-11-2014 |
Nereus Pharmaceuticals, Inc.
 Nereus Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Discovers and develops therapeutics for cancer, inflammatory, and infectious diseases | Directeur/Bestuurslid | 29-04-2013 |
Gryphon Therapeutics, Inc.
 Gryphon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and produces protein therapeutics | Directeur/Bestuurslid | 09-12-2009 |
Viracta Subsidiary, Inc.
 Viracta Subsidiary, Inc. BiotechnologyHealth Technology Develops proprietary viral gene activation therapy to address cancers associated with the epstein-barr virus | Directeur/Bestuurslid | - |
AriZeke Pharmaceuticals, Inc.
 AriZeke Pharmaceuticals, Inc. Pharmaceuticals: OtherHealth Technology Delivers therapeutic proteins and genes | Directeur/Bestuurslid | - |
Opleiding van Standish M. Fleming
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
80
Eerstegraads connecties
11
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 11 |
|---|---|
Kémia, Inc.
 Kémia, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops novel small molecule therapeutics | Health Technology |
Acorda Therapeutics, Inc.
 Acorda Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops neurology therapies | Health Technology |
Ambit Biosciences Corp.
 Ambit Biosciences Corp. Pharmaceuticals: MajorHealth Technology Develops and sells molecule kinase inhibitors for the treatment of cancer | Health Technology |
Nereus Pharmaceuticals, Inc.
Nereus Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Discovers and develops therapeutics for cancer, inflammatory, and infectious diseases | Commercial Services |
Gryphon Therapeutics, Inc.
Gryphon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and produces protein therapeutics | Health Technology |
Amherst College
 Amherst College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Forward Ventures Services LLC
Forward Ventures Services LLC Investment ManagersFinance Forward Ventures invests in companies located in the United States. The firm targets operating in the fields on life sciences and bio pharmaceuticals sectors. It provides financing for early stage capital requirements. | Finance |
AriZeke Pharmaceuticals, Inc.
AriZeke Pharmaceuticals, Inc. Pharmaceuticals: OtherHealth Technology Delivers therapeutic proteins and genes | Health Technology |
CONNECT
CONNECT Miscellaneous Commercial ServicesCommercial Services Offers education, networking and recognitions services | Commercial Services |
UCLA Anderson School of Management
 UCLA Anderson School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Viracta Subsidiary, Inc.
Viracta Subsidiary, Inc. BiotechnologyHealth Technology Develops proprietary viral gene activation therapy to address cancers associated with the epstein-barr virus | Health Technology |
